Pfizer Reaction

Barbara Ryan, sr. pharmaceutical analyst & managing director, Deutsche Bank Securities, discusses Pfizer's earnings beat and the company's outlook. She says Pfizer is on track to release a couple big drugs this year that will really benefit shareholders,...